 Laboratory Corp of America Holdings NYSE: LH has agreed to acquire Personal Genome Diagnostics Inc PGDx, a cancer genomics firm with a portfolio of comprehensive liquid biopsy and tissue-based products. Labcorp will pay 450 million in cash at closing and up to an additional 125 million on achieving future performance milestones. 